Abstract
Helicobacter cinaedi is primarily seen and diagnosed in immunocompromised patients. We present cases of primary mycotic aortitis in three immunocompetent and one immunocompromised patient caused by H cinaedi. Bacterial identification was made through perioperative samples using 16S rRNA gene sequencing, as routine culture techniques were negative owing to the slow turnaround time of H cinaedi. Successful management was achieved with a neoaortoiliac system and prolonged intravenous antibiotic therapy. All four patients had a history of having sex with men, highlighting the need to further investigate the transmission of H cinaedi in immunocompetent patients and its association with aortitis.
Keywords: Aortitis, Helicobacter cinaedi, NAIS procedure, 16S rRNA gene sequencing
Infectious aortitis carries significant morbidity and mortality rates, with Staphylococcus aureus and Salmonella spp. being the most implicated pathogens.1 Helicobacter cinaedi, a gram-negative spiral rod, was once considered an opportunistic pathogen, but is now known to infect immunocompetent individuals, mostly men having sex with men.2,3 We present four cases of H cinaedi aortitis successfully treated with long-term IV antibiotics and autologous venous reconstruction using a neoaortoiliac system (NAIS) procedure. This case series respects the SCARE criteria. Written consents were received from all patients and all cases are summarized in Table. An exemption from the Comité d’éthique de la recherche du Centre Hospitalier Universitaire de Québec-Université Laval (CER-CHU-UL) was received for this study.
Table.
Case summary of four patients with Helicobacter cinaedi aortitis
| Characteristics | Case/patient 1 | Case/patient 2 | Case/patient 3 | Case/patient 4 |
|---|---|---|---|---|
| Age, years/sex | 51/Male | 73/Male | 72/Male | 77/Male |
| Past medical history | HTN, hypothyroidism | 3.0 cm AAA | HTN, DLP, hypothyroidism, IgM MGUS, recent myocardial infarction | HIV-positive status, DLP, history of 3 cancers (gastric, bladder, prostate) |
| Risk factors for aortitis | MSM, contact with farm animals and animal carcasses | MSM, contact with animal carcasses, recent colonoscopy | MSM | MSM, forest stay |
| Chief complaint | Abdominal pain and asthenia | Fever | Abdominal pain | Abdominal pain and asthenia |
| Blood culture | Negative | Negative | Negative | Negative |
| Management | NAIS + IV antibiotics | NAIS + IV antibiotics | NAIS + IV antibiotics | NAIS + IV antibiotics |
| Antimicrobial therapy | ||||
| Before surgery | None | Piperacillin-Tazobactam | None | None |
| After surgery | Piperacillin-tazobactam + doxycycline | Imipenem + voriconazole → ceftriaxone | Piperacillin-tazobactam + tigecycline | Meropenem + doxycycline |
| At discharge (after pathogen identification) | Ceftriaxone + ciprofloxacin | Meropenem | Ciprofloxacin | Meropenem |
| Duration of treatment | 7 weeks | 6 weeks | 7 weeks | 6 weeks |
| Outcome | Alive and well at the 6-year follow-up | Alive and well at the 3-year follow-up | Alive and well at the 1-year follow-up | Alive and well at the 6-month follow-up |
AAA, Abdominal aortic aneurysm; DLP, dyslipidemia; IV, intravenous; MGUS, monoclonal gammopathy of undetermined significance; MSM, men who have sex with men; NAIS, neoaortoiliac system.
Case report 1
A 51-year-old man with known hypothyroidism consulted for abdominal pain and asthenia. Initially misdiagnosed with constipation, his symptoms worsened over a week, leading to a computed tomography scan showing an ulcerated lesion at the infrarenal aorta with surrounding soft tissue infiltration. Physical examination showed mild abdominal tenderness, normal vitals and lab tests showed normal white blood cell count and elevated C-reactive protein (50.7 mg/L). A positron emission tomography (PET) scan showed circumferential periaortic hypermetabolism (Fig 1). The patient was started on piperacillin-tazobactam and doxycycline because there were concerns of a Q fever infection and a NAIS procedure was performed. Tissue biopsy 16S rRNA gene sequencing later identified H cinaedi, prompting a change to IV ceftriaxone and ciprofloxacin for a total of 7 weeks.
Fig 1.
Positron emission tomography (PET) scan showing periaortic tissue infiltration confirming the diagnosis of aortitis in case 1.
Case report 2
A 73-year-old man presented with acute lower abdominal pain radiating to his back and chills. His past medical history was remarkable for a 3.0 cm infrarenal abdominal aortic aneurysm (AAA). On admission, his temperature was 38.3°C with normal vital signs. The patient had a history of sleeping with other men and manipulating dead animal carcasses. Physical examination was positive for a tender, pulsatile, abdominal mass. Laboratory tests showed leukocytosis (11.1 × 109 cells/L) and elevated C-reactive protein (104.0 mg/L). On computed tomography angiography (CTA), the AAA had increased in size from 3.0 to 4.5 cm over 2 years and was associated with significant retroperitoneal tissue infiltration, raising high suspicion for aortitis (Fig 2). Empirical piperacillin-tazobactam was initiated and patient underwent NAIS. Perioperative cultures demonstrated S. pneumoniae and piperacillin-tazobactam was switched for ceftriaxone. However, 16S rRNA gene sequencing on surgical tissue biopsy later identified H cinaedi prompting a change to a 6-week antibiotic treatment using meropenem.
Fig 2.
Computed tomography angiography (CTA) showing a 4.5-cm abdominal aortic aneurysm (AAA) with retroperitoneal tissue infiltration, suggestive of aortitis in case 2.
Case report 3
A 72-year-old man with hypertension, hypothyroidism, and a recent inferior myocardial infarction presented with a month-long history of progressive abdominal pain. Initially thought to be diverticulitis, he was treated with ciprofloxacin and metronidazole. CTA showed inflammation surrounding a 17-mm left common iliac aneurysm. Laboratory tests showed no leukocytosis but an elevated C-reactive protein (50.7 mg/L). PET scan confirmed a mycotic aneurysm (Fig 3). Subsequently, a NAIS procedure was performed. After surgery, the patient was treated initially with piperacillin-tazobactam and tigecycline. Later, 16S rRNA gene sequencing revealed H cinaedi as the causative agent, prompting a change to intravenous ciprofloxacin for a total of 7 weeks.
Fig 3.
Positron emission tomography (PET) scan showing a 2-cm common iliac aneurysm with infiltration confirming aortitis in case 3.
Case report 4
A 77-year-old HIV-positive man with an undetectable viral load and a history of gastric lymphoma, presented with 2 weeks of abdominal pain and fever. A CTA revealed an infrarenal aortic pseudoaneurysm. On admission, his symptoms had subsided, his vitals were stable, and all lab tests were within normal range. PET scan revealed intense uptake around the pseudoaneurysm, confirming infection (Fig 4), and the patient underwent a NAIS procedure. Postoperatively, meropenem and doxycycline were initiated, but later 16S rRNA gene sequencing identified H cinaedi. The antibiotic regiment was adjusted to meropenem alone for 6 weeks.
Fig 4.
Positron emission tomography (PET) scan showing periaortic infiltration confirming an aortitis in case 4.
Discussion
We describe four patients with aortitis caused by H cinaedi identified postoperatively by 16S rRNA gene sequencing on tissue biopsy. H cinaedi has been reported predominantly in Japan, where it has been implicated in cases of infected ascending aorta, AAA, and endocarditis. Recent studies have detected H cinaedi in the walls of clinically noninfectious AAAs and have shown the bacterium's association with atherosclerosis.4,5 This raises questions about H cinaedi's causality in certain cases of aortitis, especially when a well-established pathogen is found concomitantly, as in case 2 of our series. However, it is crucial to note that H cinaedi's role in these cases may be coincidental rather than causal, necessitating further research to delineate its pathogenic role. Owing to the low virulence of H cinaedi, infections tend to progress indolently,6 and, to date, no cases of aneurysm rupture attributed to this bacterium have been documented.7 Despite the indolent nature, we opted for NAIS for all patients, because it offers long-term durability and minimizes the risk of reinfection.
The risk of H cinaedi infection is greater in immunocompromised patients.8 Our case series describes a strong association between H cinaedi and men who have sex with men. Studies suggest that asymptomatic carriers may contribute to the transmission of H cinaedi through a fecal-oral route; the bacterium has been isolated from stool specimens.8,9 Additionally, H cinaedi has been identified in urine samples, further indicating its potential for undetected spread.9 Bacterial translocation from the intestinal tract or mucosal damage has been proposed as the most likely mechanism for H cinaedi bacteremia and vascular infections.10 Other routes of transmission remain unclear, although zoonotic transmission and nosocomial dissemination have been suggested, even in individuals with competent immune systems. Case 2 had two distinct risk factors of H. cineadi—sleeping with other men and manipulation of dead animals.2,11
Diagnosing H cinaedi is challenging owing to its microaerophilic nature and slow growth.12 Prolonged incubation times are recommended when H cinaedi bacteremia is suspected. Blood culture positivity rate is low, ranging from 0% to 22%,7,13 showing the challenging diagnosis of new pathogens in aortitis. Advances in detection techniques, such as polymerase chain reaction-based methods on tissue biopsy targeting 16S rRNA or gyrB have, significantly improved the identification of elusive pathogens.2,12,14 At our center, tissue biopsy for culture and gene sequencing is a standard of care for aortic infection. The use of 16S rRNA sequencing for definitive diagnosis proved to be essential in all patients in the series. In two cases, gene sequencing identified H cinaedi despite the presence of other pathogens on culture, demonstrating its critical role in achieving an accurate diagnosis.
The clinical management of H cinaedi infections is further complicated by the lack of established guidelines for antibiotic susceptibility testing or duration of treatment. Nevertheless, carbapenems, tetracycline, and aminoglycosides have demonstrated superior efficacy compared with penicillin and cephalosporin, although resistance to fluoroquinolones and macrolides is well-documented.7,13 When H cinaedi infection is suspected, initial empirical therapy with meropenem is suggested in the literature.15 Postsurgical antimicrobial treatment typically involves a minimum of 6 weeks of intravenous therapy, with some experts advocating for extended oral therapy lasting from 6 months to lifelong therapy.16,17 Surgical intervention remains a critical component of treatment, with open repair considered the gold standard for managing infected AAAs.18,19
Conclusions
This case series recognizes H cinaedi as a cause of infectious aortitis, previously under-recognized in immunocompetent individuals, and shows the changing face of aortic infections. Its diagnosis is challenging requiring a dedicated history of risk factors and perioperative tissue biopsy for gene sequencing. The potential of men having sex with men or zoonotic transmissions, the role of asymptomatic carriers, and the development of targeted therapies are areas that warrant continued investigation for optimal management.
Funding
None.
Disclosures
None.
Footnotes
The editors and reviewers of this article have no relevant financial relationships to disclose per the Journal policy that requires reviewers to decline review of any manuscript for which they may have a conflict of interest.
References
- 1.Sorelius K., Wyss T.R., Adam D., Beck A.W., Berard X., Budtz-Lilly J., et al. Academic Research Consortium of Infective Native Aortic A Editor's choice - Infective native aortic aneurysms: a Delphi Consensus Document on Terminology, definition, Classification, diagnosis, and reporting standards. Eur J Vasc Endovasc Surg. 2023;65:323–329. doi: 10.1016/j.ejvs.2022.11.024. [DOI] [PubMed] [Google Scholar]
- 2.Kawamura Y., Tomida J., Morita Y., Fujii S., Okamoto T., Akaike T. Clinical and bacteriological characteristics of Helicobacter cinaedi infection. J Infect Chemother. 2014;20:517–526. doi: 10.1016/j.jiac.2014.06.007. [DOI] [PubMed] [Google Scholar]
- 3.Uwamino Y., Muranaka K., Hase R., Otsuka Y., Hosokawa N. Clinical features of community-Acquired Helicobacter cinaedi bacteremia. Helicobacter. 2016;21:24–28. doi: 10.1111/hel.12236. [DOI] [PubMed] [Google Scholar]
- 4.Horii S., Sugawara H., Goto H., et al. Presence of Helicobacter cinaedi in atherosclerotic abdominal aortic aneurysmal wall. Tohoku J Exp Med. 2023;261:35–41. doi: 10.1620/tjem.2023.J049. [DOI] [PubMed] [Google Scholar]
- 5.Khan S., Rahman H.N., Okamoto T., et al. Promotion of atherosclerosis by Helicobacter cinaedi infection that involves macrophage-driven proinflammatory responses. Sci Rep. 2014;4:4680. doi: 10.1038/srep04680. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Kushimoto K., Yonekura R., Umesue M., et al. Infected Thoracic aortic aneurysm caused by Helicobacter cinaedi. Ann Vasc Dis. 2017;10:139–142. doi: 10.3400/avd.cr.16-00126. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Matsuo T., Mori N., Mizuno A., et al. Infected aortic aneurysm caused by Helicobacter cinaedi: case series and systematic review of the literature. BMC Infect Dis. 2020;20:854. doi: 10.1186/s12879-020-05582-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Araoka H., Baba M., Okada C., et al. Risk factors for recurrent Helicobacter cinaedi bacteremia and the efficacy of selective digestive decontamination with kanamycin to prevent recurrence. Clin Infect Dis. 2018;67:573–578. doi: 10.1093/cid/ciy114. [DOI] [PubMed] [Google Scholar]
- 9.Oyama K., Khan S., Okamoto T., et al. Identification of and screening for human Helicobacter cinaedi infections and carriers via nested PCR. J Clin Microbiol. 2012;50:3893–3900. doi: 10.1128/JCM.01622-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Araoka H., Baba M., Okada C., et al. First evidence of bacterial translocation from the intestinal tract as a route of Helicobacter cinaedi bacteremia. Helicobacter. 2018;23 doi: 10.1111/hel.12458. [DOI] [PubMed] [Google Scholar]
- 11.Kitamura T., Kawamura Y., Ohkusu K., et al. Helicobacter cinaedi cellulitis and bacteremia in immunocompetent hosts after orthopedic surgery. J Clin Microbiol. 2007;45:31–38. doi: 10.1128/JCM.01507-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Araoka H., Baba M., Kimura M., Abe M., Inagawa H., Yoneyama A. Clinical characteristics of bacteremia caused by Helicobacter cinaedi and time required for blood cultures to become positive. J Clin Microbiol. 2014;52:1519–1522. doi: 10.1128/JCM.00265-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Matsumoto T., Goto M., Murakami H., et al. Multicenter study to evaluate bloodstream infection by Helicobacter cinaedi in Japan. J Clin Microbiol. 2007;45:2853–2857. doi: 10.1128/JCM.00465-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Akiyama M., Hayatsu Y., Sakatsume K., et al. Graft placement with an omental flap for ruptured infective common iliac aneurysm in a patient with a continuous flow left ventricular assist device: alternative surgical approach avoiding driveline injury and pathogen identification by 16S ribosomal DNA gene analysis. J Artif Organs. 2016;19:383–386. doi: 10.1007/s10047-016-0916-7. [DOI] [PubMed] [Google Scholar]
- 15.Shimizu Y., Gomi H., Ishioka H., Isono M. Refractory to treat Helicobacter cinaedi bacteremia with bilateral lower extremities cellulitis in an immunocompetent patient. IDCases. 2016;5:9–11. doi: 10.1016/j.idcr.2016.05.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Heinola I., Sorelius K., Wyss T.R., et al. Open repair of mycotic abdominal aortic aneurysms with biological grafts: an international multicenter study. J Am Heart Assoc. 2018;7 doi: 10.1161/JAHA.117.008104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Saito J., Rimbara E., Inaguma S., et al. Determining infected aortic aneurysm treatment using focused detection of helicobacter cinaedi. Emerg Infect Dis. 2022;28:1494–1498. doi: 10.3201/eid2807.212505. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Semaan D.B., Habib S.G., Madigan M., et al. A comparison of surgical techniques and outcomes for primary infected abdominal aortic aneurysms. Ann Vasc Surg. 2024;101:209–218. doi: 10.1016/j.avsg.2023.11.021. [DOI] [PubMed] [Google Scholar]
- 19.Shirasu T., Kuno T., Yasuhara J., et al. Meta-analysis finds recurrent infection is more common after endovascular than after open repair of infected abdominal aortic aneurysm. J Vasc Surg. 2022;75:348–355.e10. doi: 10.1016/j.jvs.2021.07.240. [DOI] [PubMed] [Google Scholar]




